ARTHUR S KIRSCH
CIK 1290976 · last filed 2026-06-03
ARTHUR S KIRSCH is a corporate insider who has filed 44 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing shows the insider sold $1.7M of LQDA on Jun 3, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.90M
7
44
-$1.19M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LQDA | Director | 40,755 | $71.23 | $2.90M | -$1.60M | 9 | 2026-06-03 |
| EVMN | Director | — | $19.83 | — | $0 | 1 | 2026-06-03 |
| AVIR | Director | — | $4.49 | — | $0 | 1 | 2025-02-24 |
| Kadmon Holdings, Inc. (KDMN) Delisted | Director | 0 | $9.50 | $0 | $0 | 5 | 2021-11-09 |
| Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Director | 276,609 | — | — | $347.5K | 9 | 2017-12-12 |
| POZEN INC /NC (POZN) Delisted | Director | 58,612 | — | — | $66.5K | 11 | 2016-01-22 |
| IMMUNOMEDICS INC (IMMU) Delisted | Director | — | — | — | $0 | 2 | 2015-12-04 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | LQDA | Sell (S) | −30,000 | -$1.73M | EDGAR |
| 2026-06-03 | EVMN | Grant (A) | — | $0 | EDGAR |
| 2025-11-07 | — | Grant (A) | — | $0 | |
| 2025-06-20 | LQDA | Grant (A) | +18,396 | $0 | EDGAR |
| 2025-02-24 | AVIR | Grant (A) | — | $0 | EDGAR |
| 2024-06-24 | LQDA | Grant (A) | +20,359 | $0 | EDGAR |
| 2023-11-22 | LQDA | — | — | $0 | EDGAR |
| 2023-06-21 | LQDA | Grant (A) | — | $0 | EDGAR |
| 2022-06-22 | LQDA | Grant (A) | — | $0 | EDGAR |
| 2021-11-12 | LQDA | Buy (P) | +30,000 | $127.2K | EDGAR |